Healthcare >> CEO Interviews >> May 29, 2000

Norman Russell – Lynx Therapeutics Inc (lynx)

NORMAN J.W. RUSSELL, PhD, joined Lynx in July 1999 as President and Chief Executive Officer. Prior to that he was Head of Biological Science and Technology at AstraZeneca Pharmaceuticals. His previous positions in 20 years at Zeneca included Head of Target Discovery, Head of International Genomics, and Head of Biotechnology. Dr. Russell gained his PhD from Glasgow University, Scotland in 1977. Profile
TWST: Could we start out with an overview and a little history of Lynx,

just to set the stage for readers?

Dr. Russell: Lynx is a leader in developing and applying novel

technologies for the